Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05906316 · ClinicalTrials.gov registry record
A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study
A clinical trial of Mycobacterium Avium Complex Pulmonary Disease, sponsored by Radboud University Medical Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 11
- Study locations
NCT05906316: Recruiting study of Mycobacterium Avium Complex Pulmonary Disease, sponsored by Radboud University Medical Center.
NCT05906316 is a study of Mycobacterium Avium Complex Pulmonary Disease that is actively recruiting participants, run by Radboud University Medical Center. The registered enrollment target is 100 participants. The trial reports 11 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05906316, a study of Mycobacterium Avium Complex Pulmonary Disease, is actively recruiting participants, sponsored by Radboud University Medical Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 11
- Study locations
Study Summary
To gain insight in the effectiveness of, adherence and adjustments to guideline-based three-drug antimycobacterial therapy in patients with Mycobacterium avium complex pulmonary disease (MAC-PD) during the first 6 months of treatment.
Primary Outcome
Conversion from positive cultures at baseline to negative cultures after 6 months of antimycobacterial treatment, defined by three or more negative sputum cultures sampled a month apart or one negative culture from a bronchial lavage.
Conditions Studied
Study Locations (11)
Other
- UZ Leuven - Leuven
- University Hospital Center Zagreb - Zagreb
- Aarhus University Hospital - Aarhus
- Rasmus Rude Laub - Hellerup
- University Hospital Frankfurt - Frankfurt
- Fukujuji Hospital - Tokyo
- Radboud University Medical Center - Nijmegen
- Seoul National University Hospital - Seoul
- Hospital Clínic de Barcelona - Barcelona
Oregon
- Oregon Science and Health University - Portland
Alberta
- University of Calgary - Calgary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-07-01 |
| Est. Completion | 2026-07-01 |
What NCT05906316 shows while recruiting
NCT05906316 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Mycobacterium Avium Complex Pulmonary Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05906316 lists 11 locations in 3 states (Other, Oregon, Alberta).
Frequently Asked Questions
What is clinical trial NCT05906316 about?
NCT05906316 is a clinical study titled "A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study". To gain insight in the effectiveness of, adherence and adjustments to guideline-based three-drug antimycobacterial therapy in patients with Mycobacterium avium complex pulmonary disease (MAC-PD) during the first 6 months of treatment.
What is the current status of trial NCT05906316?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-07-01. Estimated completion is 2026-07-01.
What conditions does trial NCT05906316 study?
This clinical trial studies the following conditions: Mycobacterium Avium Complex Pulmonary Disease.
Who is sponsoring clinical trial NCT05906316?
This trial is sponsored by Radboud University Medical Center, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05906316 being conducted?
This trial has 11 study locations across Oregon, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI